Immune Oncology Research Institute

This study tests whether the drug balstilimab is safe and can shrink tumors in people with certain lymphomas (Hodgkin or primary mediastinal B-cell) that have returned or not responded to standard treatments. About 20 adults will receive the drug every 3 weeks. The main goal is t…

This study is creating a worldwide database of people with a very rare blood cancer called BPDCN. Researchers will collect information on how the disease appears, how it is treated, and what happens to patients over time. The goal is to learn from real-world cases to help doctors…

This study is building a large international database of 500 people diagnosed with cardiac angiosarcoma, a rare and deadly heart cancer. Researchers will collect medical history, treatment details, and outcomes to identify risk factors and determine which treatments work best. No…